Two Sigma Investments, LP Bolt Biotherapeutics, Inc. Transaction History

Two Sigma Investments, LP

  • $41.1 Billion
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
BUY
$1.41 - $2.91 $23,903 - $49,333
16,953 Added 95.24%
34,754 $71,000
Q1 2022

May 16, 2022
SELL
$2.74 - $4.82 $21,095 - $37,109
-7,699 Reduced 30.19%
17,801 $49,000
Q4 2021

Feb 14, 2022
BUY
$4.19 - $13.97 $106,845 - $356,235
25,500 New
25,500 $125,000
Q3 2021

Nov 15, 2021
SELL
$11.15 - $18.6 $136,966 - $228,482
-12,284 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$15.4 - $31.46 $189,173 - $386,454
12,284 New
12,284 $190,000

Others Institutions Holding BOLT

# of Institutions
38
Shares Held
23M
Call Options Held
0
Put Options Held
0
View Full List

About Bolt Biotherapeutics, Inc.

BOLT Quotes by TradingView
  • Ticker BOLT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,641,500
  • Market Cap $23.3M
  • Description
  • Bolt Biotherapeutics, Inc., a clinical-stage biotechnology company, engages in the development of immuno-oncology agents to target tumor cells for elimination by the immune system. The company is developing BDC-1001, a human epidermal growth factor receptor 2 (HER2), which is in Phase I/II clinical trial for the treatment of patients with HER2-e...
More about BOLT
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email